Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data

This publication has 36 references indexed in Scilit:

• Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience
  Vaccine, 2012
• Changes in Serogroup and Genotype Prevalence Among Carried Meningococci in the United Kingdom During Vaccine Implementation
  The Journal of Infectious Diseases, 2011
• Costs and impact of meningitis epidemics for the public health system in Burkina Faso
  Vaccine, 2011
• The future of immunisation policy, implementation, and financing
  The Lancet, 2011
• Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans
  New England Journal of Medicine, 2011
• Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina Faso
  PLOS ONE, 2011
• Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a Meningococcal Serogroup A Conjugate Vaccine
  Clinical and Vaccine Immunology, 2011
• Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd Immunity
  Clinical and Vaccine Immunology, 2010
• Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity
  The Journal of Infectious Diseases, 2008
• Clonal Waves of Neisseria Colonisation and Disease in the African Meningitis Belt: Eight- Year Longitudinal Study in Northern Ghana
  PLoS Medicine, 2007